Vladyslava Inman
Acute Care · Southaven, MSNPI 1306459516
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,318, 9.1 times the $254 reported in 2021.
Across 121 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$628
- Harmony Biosciences LLC$302
- Regeneron Healthcare Solutions, Inc.$238
- GSK$203
- Insmed, Inc.$191
- Pulmonx Corporation$150
- plus $981 from 20 others
What the payments were for
- Food & beverage$2,67599%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $628 |
| Harmony Biosciences LLC | 10 | $302 |
| Regeneron Healthcare Solutions, Inc. | 8 | $238 |
| GSK | 13 | $203 |
| Insmed, Inc. | 14 | $191 |
| Pulmonx Corporation | 1 | $150 |
| Boehringer Ingelheim | 8 | $148 |
| Viatris Specialty LLC | 6 | $141 |
| Sanofi | 5 | $111 |
| Verona Pharma, Inc. | 4 | $77 |
| Lilly USA, LLC | 5 | $74 |
| Genentech USA, Inc. | 3 | $62 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| Actelion Pharmaceuticals US, Inc. | 2 | $43 |
| Merck | 2 | $35 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Amgen | 2 | $29 |
| Haemonetics Corporation | 1 | $28 |
| Ambu Inc. | 1 | $24 |
| United Therapeutics Corporation | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Mylan Specialty L.p. | 1 | $16 |
| La Jolla Pharmaceutical Company | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,692 in reported general payments places this provider in the 80th percentile of 223 acute care providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Southaven
- William HardySouthaven$2K
- Christopher BellTupelo$348K
- Kathleen ArnoldOcean Springs$217K
- Gavin GistOxford$42K
- Jamie DamicoOcean Springs$17K
- Dylan BoydHattiesburg$15K
- Melinda ClarkStarkville$14K
- Michelle TaylorGulfport$13K
- Aaron KatzenmeyerMadison$12K
- Megan WilliamsTupelo$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.